License Covers Novel Molecular Entity Developed by the Walter Reed Army Institute of Research The HT-006 active pharmaceutical ingredient is expected to be a broad-spectrum antibiotic for treatment of serious bacterial infections of the lung NEW YORK, Jan. 4, 2021 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company,… Read More..
HDF Assist Device Complete; Special 510(k) to be Filed in Early 2021 Nephros Granted Patent Covering Technology in HDF Assist Module Nephros Expands EndoPur® and S100 Filter Labels to Include Heat Disinfection SOUTH ORANGE, NJ, Jan. 04, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros, Inc. (Nasdaq: NEPH), a commercial-stage… Read More..
CHICAGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exicure, Inc. (NASDAQ: XCUR), a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA™) technology, will host a virtual R&D Day on Thursday, January 7, 2021 from 09:00 am to 10:30 am ET to discuss Exicure’s neuroscience pipeline, including its lead program for… Read More..